Solid phase extraction and high performance liquid chromatography for the determination of azithromycin in human plasma

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 6, 2008, Pages 978-987

  Supattanapong, Sukanya ^a   Konsil, Julraht ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56849107328     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Andersen SL, Ager AL, McGreevy P, Schuster BG, Ellis W, Berman J. Efficacy of azithromycin as a causal prophylactic agent against murine malaria. Antimicrob Agents Chemother 1994; 38: 1862-3.
2. Anderson SL, Berman J, Kuschner R, et al. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 1995; 123: 771-3.
3. Andreotti D, Bientinesi I, Biondi S, et al. A novel ketolide class: Synthesis and antibacterial activity of a lead compound. Bioorg Med Chem Lett 2007; 17: 5265-9. Epub 2007 Feb 9.
4. Bahrami G, Mirzae S, Kiani A. High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies. J Chromatogr B 2005; 820: 277-81.
5. Bahrami G, Mohammadi B. A new on-line, in-tube pre-column derivatization technique for high performance liquid chromatographic determination of azithromycin in human serum. J Chromatogr B 2006; 830: 355-8.
6. Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham MJ. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005; 49: 2372-7.
7. Breitschwerdt EB, Papich MG, Hegarty BC, Gilger B, Hancock SI, Davidson MG. Efficacy of doxycycline, azithromycin, ortrovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob Agents Chemother 1999; 43: 813-21.
8. Cárceles CM, Font A, Espuny A, Fernandez-Varón E, Serrano JM, Escudero E. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats. J Vet Pharmacol Ther 2005; 28: 51-5.
9. Chen B-M, Liang Y-Z, Chen X, Liu S-G, Deng F-L, Zhou P. Quantitative determination of azithromycin in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study. J Pharm Biomed Anal 2006; 42: 480-7.
10. Chen L, Qin F, Ma Y, Li F. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 855: 255-61. Epub 2007 May 26.
11. Ghouse M, Maulana AB, Mohamed Ali MG, Sarasa VD. A two-year study of the efficacy of azithromycin in the treatment of leptospirasis in humans. Indian J Med Microbiol 2006; 24: 345-6.
12. Girard AE, Girard D, English AR, et al. Pharmacokinetic and In vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 1987; 31: 1948-54.
13. Heppner DG Jr, Walsh DS, Uthaimongkol N, et al. Randomized, controlled double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in western Thailand. Am J Trop Med Hyg 2005; 73: 842-9.
14. Hoepelmana IM, Schneide MME. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 1995; 5: 145-67.
15. Kalilani L, Mofolo I, Chaponda M, et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS ONE 2007; 2: e1166.
16. Ke J, Lewis J, Hidy BJ. Quantitation of azithromycin in human plasma via HPLC with MS/MS detection. Orlando, Florida: Proceedings of the 50th ASMS Conference on Mass Spectrometry and Allied Topics, 2002.
17. Kees F, Spangler S, Wellenhofer M. Determination of macrolides in biological matrices by high performance liquid chromatography with electrochemical detection. J Chromatogr A 1998; 812: 287-93.
18. Krudsood S, Silachamroon U, Wilairatana P, et al. A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 801-7.
19. Liu F, Xu Y, Huang J, Gao S, Guo Q. Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma [Abstract]. Biomed Chromatogr 2007; 21: 1272-8.
20. Miller RS, Wongsrichanalai C, Buathong N, et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycinquinine combinations: a randomized, doseranging study. Am J Trop Med Hyg 2006; 74: 401-6.
21. Murray CK, Ellis MW, Hospenthal DR. Susceptibility of Leptospira serovars to antimalarial agents. Am J Trop Med Hyg 2004; 71: 685-6.
22. Noedl H, Krudsood S, Chalermratana K, et al. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis 2006; 43: 1264-71. Epub 2006 Oct 12.
23. Noedl H, Wernsdorfer WH, Krudsood S, et al. Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. Acta Trop 2001; 80: 39-44.
24. Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2002; 46: 2518-24.
25. Phimda K, Hoontrakul S, Suttinont C. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007; 51: 3259-63. Epub 2007 Jul 16.
26. Riedel K-D, Wildfeuer A, Laufen H, Zimmermann T. Equivalence of a HPLC assay and a bioassay of azithromycin in human serum samples. J Chromatogr 1992; 576: 358-62.
27. US Department of Health and Human Services Food and Drug Administration (US FDA). Guidance for industry: bioanalytical method validation. FDA/CDER/CVM, 2001. [Cited 2006 May 2], Available from: URL: http://www.fda.aov/cder/guidance/4252fnl.pdf
28. Xue-Min Z, Jie L, Juan G, Quan-Sheng Y, Wen-Yan W. Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics. Pharmazie 2007; 62: 255-7.